Emmi, Giacomo http://orcid.org/0000-0001-9575-8321
Bettiol, Alessandra
Gelain, Elena
Bajema, Ingeborg M.
Berti, Alvise http://orcid.org/0000-0002-7831-921X
Burns, Stella
Cid, Maria C. http://orcid.org/0000-0002-4730-0938
Cohen Tervaert, Jan W.
Cottin, Vincent http://orcid.org/0000-0002-5591-0955
Durante, Eugenia
Holle, Julia U.
Mahr, Alfred D.
Del Pero, Marcos Martinez
Marvisi, Chiara
Mills, John
Moiseev, Sergey
Moosig, Frank
Mukhtyar, Chetan
Neumann, Thomas
Olivotto, Iacopo
Salvarani, Carlo
Seeliger, Benjamin http://orcid.org/0000-0001-7373-752X
Sinico, Renato A.
Taillé, Camille
Terrier, Benjamin
Venhoff, Nils http://orcid.org/0000-0001-7729-2759
Bertsias, George http://orcid.org/0000-0001-5299-1406
Guillevin, Loïc
Jayne, David R. W. http://orcid.org/0000-0002-1712-0637
Vaglio, Augusto http://orcid.org/0000-0002-3814-9172
Article History
Accepted: 24 March 2023
First Online: 9 May 2023
Competing interests
: N.V. has received speaking and consulting fees from GSK. B.S. has received advisory and/or speaker fees from Boehringer Ingelheim and GSK. A.V. has received speaking and consulting fees from GSK, Otsuka and Vifor. G.E. has received speaking and consulting fees from AstraZeneca, Boehring Ingelheim, GSK, Janssen, Novartis, Otsuka, Roche and Sobi, and R.A.S. has received advisory and consulting fees from GSK, Otsuka and Roche. A. Berti has received speaking and consulting fees from GSK. The other authors declare no competing interests.
Free to read: This content has been made available to all.